| II-VI Incorporated and Subsidiaries | ||||||||||
| Condensed Consolidated Statements of Cash Flows (Unaudited) | ||||||||||
| ($000) | Year Ended | |||||||||
| June 30, | ||||||||||
| 2022 | 2021 | |||||||||
| Cash Flows from Operating Activities | ||||||||||
| Net cash provided by operating activities | $ | 413,332 | $ | 574,353 | ||||||
| Cash Flows from Investing Activities | ||||||||||
| Additions to property, plant & equipment | (314,332 | ) | (146,337 | ) | ||||||
| Purchases of businesses, net of cash acquired | — | (34,394 | ) | |||||||
| Other investing activities | (5,750 | ) | 7,774 | |||||||
| Net cash used in investing activities | (320,082 | ) | (172,957 | ) | ||||||
| Cash Flows from Financing Activities | ||||||||||
| Proceeds from issuance of Senior Notes | 990,000 | — | ||||||||
| Proceeds from issuance of common shares | — | 460,000 | ||||||||
| Proceeds from issuance of Series A preferred shares | — | 460,000 | ||||||||
| Proceeds from issuance of Series B preferred shares | — | 750,000 | ||||||||
| Payment on Finisar Notes | (14,888 | ) | — | |||||||
| Payments on borrowings under Term A Facility | (62,050 | ) | (137,050 | ) | ||||||
| Payments on borrowings under Term B Facility | — | (714,600 | ) | |||||||
| Payments on borrowings under Revolving Credit Facility | — | (74,000 | ) | |||||||
| Debt issuance costs | (10,197 | ) | — | |||||||
| Equity issuance costs | — | (58,596 | ) | |||||||
| Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan | 17,858 | 32,360 | ||||||||
| Payments in satisfaction of employees' minimum tax obligations | (21,249 | ) | (19,701 | ) | ||||||
| Payment of dividends | (34,508 | ) | (20,319 | ) | ||||||
| Other financing activities | (2,013 | ) | (2,367 | ) | ||||||
| Net cash provided by financing activities | 862,953 | 675,727 | ||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 34,276 | 21,723 | ||||||||
| Net increase in cash, cash equivalents and restricted cash | 990,479 | 1,098,846 | ||||||||
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 1,591,892 | 493,046 | ||||||||
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $ | 2,582,371 | $ | 1,591,892 | ||||||
II-VI Incorporated Reports Q4 and Full-Year Fiscal 2022 Results
 |  | More IC News
|
|
RELATED NEWS
